IRS-2 expression levels are low in LNCap cells, which represents an indolent form of prostate cancer, while IRS-2 expression levels are high in PC3 and DU145 cells, which are highly aggressive prostate cancer cell types [12]. This evidence concerns the gene IRS2 and prostate cancer.